FDA greenlights GSK’s drug for UTIs in women and girls
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...
23andMe Bankruptcy: What Happens To Your DNA Data When A Genetic Testing Giant Fails?
The collapse of 23andMe is sparking important conversations — and unanswered questions — about genetic data privacy and ...
Dechert to Defend GSK in Securities Class Action Over Alleged Link Between Zantac and Carcinogenic Compound
This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state and federal courts. Click here to get started and be first to act on ...
There’s a New Pill to Treat UTIs
On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK studying if best-selling shingles vaccine lowers dementia risk
GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...
Deutsche Bank Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...